390
N. Ashwin Kumar et al.
albumin natural molecule for chemoradiation therapy aim. Artif Cells Nanomed Biotechnol
47(1):3832–3838. https://doi.org/10.1080/21691401.2019.1669624
107. Azizi S, Nosrati H, Sharafi A, Danafar H (2019) Preparation of bismuth sulfide nanoparticles
as targeted biocompatible nano-radiosensitizer and carrier of methotrexate. Appl Organomet
Chem 34(1). https://doi.org/10.1002/aoc.5251
108. Nosrati H, Charmi J, Salehiabar M, Abhari F, Danafar H (2019) Tumor targeted albumin
coated bismuth sulfide nanoparticles (Bi2S3) as radiosensitizers and carriers of curcumin for
enhanced chemoradiation therapy. ACS Biomater Sci Eng 5(9):4416–4424. https://doi.org/
10.1021/acsbiomaterials.9b00489
109. Zhou D, Li C, He M, Ma M, Li P, Gong Y, Ran H, Wang Z, Wang Z, Zheng Y, Sun Y (2016)
Folate-targeted perfluorohexane nanoparticles carrying bismuth sulfide for use in US/CT dualmode imaging and synergistic high-intensity focused ultrasound ablation of cervical cancer.
J Mater Chem B 4(23):4164–4181. https://doi.org/10.1039/c6tb00261g
110. Oh MH, Lee N, Kim H, Park SP, Piao Y, Lee J, Jun SW, Moon WK, Choi SH, Hyeon T
(2011) Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed
tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem
Soc 133(14):5508–5515. https://doi.org/10.1021/ja200120k
111. Matsuno H (2001) Biocompatibility and osteogenesis of refractory metal implants, titanium,
hafnium, niobium, tantalum and rhenium. Biomaterials 22(11):1253–1262. https://doi.org/
10.1016/s0142-9612(00)00275-1
112. Bonitatibus PJ Jr, Torres AS, Kandapallil B, Lee BD, Goddard GD, Colborn RE, Marino ME
(2012) Preclinical assessment of a zwitterionic tantalum oxide nanoparticle X-ray contrast
agent. ACS Nano 6(8):6650–6658. https://doi.org/10.1021/nn300928g
113. Lee N, Yoo D, Ling D, Cho MH, Hyeon T, Cheon J (2015) Iron oxide based nanoparticles
for multimodal imaging and magnetoresponsive therapy. Chem Rev 115(19):10637–10689.
https://doi.org/10.1021/acs.chemrev.5b00112
114. Torres AS, Bonitatibus PJ Jr, Colborn RE, Goddard GD, FitzGerald PF, Lee BD, Marino ME
(2012) Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle
x-ray contrast agent. Invest Radiol 47(10):578–587. https://doi.org/10.1097/RLI.0b013e318
260fc40
115. Freedman JD, Lusic H, Snyder BD, Grinstaff MW (2014) Tantalum oxide nanoparticles
for the imaging of articular cartilage using X-ray computed tomography: visualization
of ex vivo/in vivo murine tibia and ex vivo human index finger cartilage. Angew Chem
53(32):8406–8410. https://doi.org/10.1002/anie.201404519
116. Crowder JM, Bates N, Roberts J, Torres AS, Bonitatibus PJ (2016) Determination of tantalum
from tantalum oxide nanoparticle X-ray/CT contrast agents in rat tissues and bodily fluids by
ICP-OES. J Anal At Spectrom 31(6):1311–1317. https://doi.org/10.1039/c5ja00446b
117. Song G, Chen Y, Liang C, Yi X, Liu J, Sun X, Shen S, Yang K, Liu Z (2016) Catalaseloaded taox nanoshells as bio-nanoreactors combining high-Z element and enzyme delivery
for enhancing radiotherapy. Adv Mater 28(33):7143–7148. https://doi.org/10.1002/adma.201
602111
118. Chen Y, Song G, Dong Z, Yi X, Chao Y, Liang C, Yang K, Cheng L, Liu Z (2017) Drug-loaded
mesoporous tantalum oxide nanoparticles for enhanced synergetic chemoradiotherapy with
reduced systemic toxicity. Small 13(8). https://doi.org/10.1002/smll.201602869
119. Jin Y, Ma X, Zhang S, Meng H, Xu M, Yang X, Xu W, Tian J (2017) A tantalum oxide-based
core/shell nanoparticle for triple-modality image-guided chemo-thermal synergetic therapy of
esophageal carcinoma. Cancer Lett 397:61–71. https://doi.org/10.1016/j.canlet.2017.03.030
120. Peng C, Liang Y, Chen Y, Qian X, Luo W, Chen S, Zhang S, Dan Q, Zhang L, Li M, Yuan
M, Zhao B, Li Y (2020) Hollow mesoporous tantalum oxide based nanospheres for triple
sensitization of radiotherapy. ACS Appl Mater Interfaces 12(5):5520–5530. https://doi.org/
10.1021/acsami.9b20053
121. Rajasekar S, Martin EM, Kuppusamy S, Vetrivel C (2020) Chitosan coated molybdenum
sulphide nanosheet incorporated with tantalum oxide nanomaterials for improving cancer
photothermal therapy. Arab J Chem 13(3):4741–4750. https://doi.org/10.1016/j.arabjc.2019.
11.005
N. Ashwin Kumar et al.
albumin natural molecule for chemoradiation therapy aim. Artif Cells Nanomed Biotechnol
47(1):3832–3838. https://doi.org/10.1080/21691401.2019.1669624
107. Azizi S, Nosrati H, Sharafi A, Danafar H (2019) Preparation of bismuth sulfide nanoparticles
as targeted biocompatible nano-radiosensitizer and carrier of methotrexate. Appl Organomet
Chem 34(1). https://doi.org/10.1002/aoc.5251
108. Nosrati H, Charmi J, Salehiabar M, Abhari F, Danafar H (2019) Tumor targeted albumin
coated bismuth sulfide nanoparticles (Bi2S3) as radiosensitizers and carriers of curcumin for
enhanced chemoradiation therapy. ACS Biomater Sci Eng 5(9):4416–4424. https://doi.org/
10.1021/acsbiomaterials.9b00489
109. Zhou D, Li C, He M, Ma M, Li P, Gong Y, Ran H, Wang Z, Wang Z, Zheng Y, Sun Y (2016)
Folate-targeted perfluorohexane nanoparticles carrying bismuth sulfide for use in US/CT dualmode imaging and synergistic high-intensity focused ultrasound ablation of cervical cancer.
J Mater Chem B 4(23):4164–4181. https://doi.org/10.1039/c6tb00261g
110. Oh MH, Lee N, Kim H, Park SP, Piao Y, Lee J, Jun SW, Moon WK, Choi SH, Hyeon T
(2011) Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed
tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem
Soc 133(14):5508–5515. https://doi.org/10.1021/ja200120k
111. Matsuno H (2001) Biocompatibility and osteogenesis of refractory metal implants, titanium,
hafnium, niobium, tantalum and rhenium. Biomaterials 22(11):1253–1262. https://doi.org/
10.1016/s0142-9612(00)00275-1
112. Bonitatibus PJ Jr, Torres AS, Kandapallil B, Lee BD, Goddard GD, Colborn RE, Marino ME
(2012) Preclinical assessment of a zwitterionic tantalum oxide nanoparticle X-ray contrast
agent. ACS Nano 6(8):6650–6658. https://doi.org/10.1021/nn300928g
113. Lee N, Yoo D, Ling D, Cho MH, Hyeon T, Cheon J (2015) Iron oxide based nanoparticles
for multimodal imaging and magnetoresponsive therapy. Chem Rev 115(19):10637–10689.
https://doi.org/10.1021/acs.chemrev.5b00112
114. Torres AS, Bonitatibus PJ Jr, Colborn RE, Goddard GD, FitzGerald PF, Lee BD, Marino ME
(2012) Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle
x-ray contrast agent. Invest Radiol 47(10):578–587. https://doi.org/10.1097/RLI.0b013e318
260fc40
115. Freedman JD, Lusic H, Snyder BD, Grinstaff MW (2014) Tantalum oxide nanoparticles
for the imaging of articular cartilage using X-ray computed tomography: visualization
of ex vivo/in vivo murine tibia and ex vivo human index finger cartilage. Angew Chem
53(32):8406–8410. https://doi.org/10.1002/anie.201404519
116. Crowder JM, Bates N, Roberts J, Torres AS, Bonitatibus PJ (2016) Determination of tantalum
from tantalum oxide nanoparticle X-ray/CT contrast agents in rat tissues and bodily fluids by
ICP-OES. J Anal At Spectrom 31(6):1311–1317. https://doi.org/10.1039/c5ja00446b
117. Song G, Chen Y, Liang C, Yi X, Liu J, Sun X, Shen S, Yang K, Liu Z (2016) Catalaseloaded taox nanoshells as bio-nanoreactors combining high-Z element and enzyme delivery
for enhancing radiotherapy. Adv Mater 28(33):7143–7148. https://doi.org/10.1002/adma.201
602111
118. Chen Y, Song G, Dong Z, Yi X, Chao Y, Liang C, Yang K, Cheng L, Liu Z (2017) Drug-loaded
mesoporous tantalum oxide nanoparticles for enhanced synergetic chemoradiotherapy with
reduced systemic toxicity. Small 13(8). https://doi.org/10.1002/smll.201602869
119. Jin Y, Ma X, Zhang S, Meng H, Xu M, Yang X, Xu W, Tian J (2017) A tantalum oxide-based
core/shell nanoparticle for triple-modality image-guided chemo-thermal synergetic therapy of
esophageal carcinoma. Cancer Lett 397:61–71. https://doi.org/10.1016/j.canlet.2017.03.030
120. Peng C, Liang Y, Chen Y, Qian X, Luo W, Chen S, Zhang S, Dan Q, Zhang L, Li M, Yuan
M, Zhao B, Li Y (2020) Hollow mesoporous tantalum oxide based nanospheres for triple
sensitization of radiotherapy. ACS Appl Mater Interfaces 12(5):5520–5530. https://doi.org/
10.1021/acsami.9b20053
121. Rajasekar S, Martin EM, Kuppusamy S, Vetrivel C (2020) Chitosan coated molybdenum
sulphide nanosheet incorporated with tantalum oxide nanomaterials for improving cancer
photothermal therapy. Arab J Chem 13(3):4741–4750. https://doi.org/10.1016/j.arabjc.2019.
11.005